Aveanna Healthcare Holdings Inc. (AVAH)
USD 4.84
(7.56%)
USD 4.84
(7.56%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.89 Billion USD | 6.02% |
| 2022 | 1.78 Billion USD | 6.5% |
| 2021 | 1.67 Billion USD | 12.27% |
| 2020 | 1.49 Billion USD | 8.02% |
| 2019 | 1.38 Billion USD | 10.4% |
| 2018 | 1.25 Billion USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 490.65 Million USD | 2.47% |
| 2024 Q2 | 504.95 Million USD | 2.92% |
| 2023 Q1 | 466.41 Million USD | 3.38% |
| 2023 FY | 1.89 Billion USD | 6.02% |
| 2023 Q4 | 478.84 Million USD | 0.17% |
| 2023 Q3 | 478.01 Million USD | 1.29% |
| 2023 Q2 | 471.94 Million USD | 1.19% |
| 2022 Q2 | 442.95 Million USD | -1.68% |
| 2022 Q1 | 450.53 Million USD | 8.81% |
| 2022 Q4 | 451.14 Million USD | 1.84% |
| 2022 FY | 1.78 Billion USD | 6.5% |
| 2022 Q3 | 443 Million USD | 0.01% |
| 2021 Q4 | 414.07 Million USD | 0.68% |
| 2021 FY | 1.67 Billion USD | 12.27% |
| 2021 Q3 | 411.27 Million USD | -5.69% |
| 2021 Q1 | 417.16 Million USD | -1.22% |
| 2021 Q2 | 436.11 Million USD | 4.54% |
| 2020 FY | 1.49 Billion USD | 8.02% |
| 2020 Q4 | 422.3 Million USD | 15.38% |
| 2020 Q3 | 366 Million USD | 4.1% |
| 2020 Q2 | 351.57 Million USD | -1.03% |
| 2020 Q1 | 355.22 Million USD | 0.0% |
| 2019 FY | 1.38 Billion USD | 10.4% |
| 2018 FY | 1.25 Billion USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 35.289% |
| Addus HomeCare Corporation | 1.05 Billion USD | -79.021% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -867.353% |
| Amedisys, Inc. | 2.23 Billion USD | 15.256% |
| Astrana Health, Inc. | 1.38 Billion USD | -36.674% |
| IMAC Holdings, Inc. | 5.19 Million USD | -36367.366% |
| biote Corp. | 185.36 Million USD | -922.448% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -5946.54% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 6.165% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | -203.579% |
| The Ensign Group, Inc. | 3.72 Billion USD | 49.181% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | -13.391% |
| InnovAge Holding Corp. | 763.85 Million USD | -148.111% |
| The Joint Corp. | 117.69 Million USD | -1510.253% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | -79.528% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -18196.142% |
| ModivCare Inc. | 2.75 Billion USD | 31.113% |
| NewGenIvf Group Limited | 5.13 Million USD | -36799.388% |
| Option Care Health, Inc. | 4.3 Billion USD | 55.949% |
| P3 Health Partners Inc. | 1.26 Billion USD | -49.656% |
| P3 Health Partners Inc. | 1.26 Billion USD | -49.656% |
| The Pennant Group, Inc. | 544.89 Million USD | -247.814% |
| Surgery Partners, Inc. | 2.74 Billion USD | 30.915% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -34263.726% |
| Talkspace, Inc. | 150.04 Million USD | -1163.094% |
| Talkspace, Inc. | 150.04 Million USD | -1163.094% |
| The Oncology Institute, Inc. | 324.23 Million USD | -484.51% |
| The Oncology Institute, Inc. | 324.23 Million USD | -484.51% |